Immunitybio Inc (IBRX)
$3.43 $0.02 (0.44%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.74B -
Day's Range
$3.38 - $3.48 -
Volume
2,551,530 -
52 Week Low / High
$1.25 - $10.53 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
IBRX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.50
- Target Price
Company News
-
Phase 2 data presented at the World Conference on Lung Cancer showing a prolonged median overall survival of over 14 months in 2nd and 3rd line NSCLC cancer patients who progressed on checkpoint inhibitors such as KEYTRUDA (pembrolizumab) and OPDIVO (nivolumab) ANKTIVA plus KEYTRUDA or OPD...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$